Final Written News Today

Welcome to this issue of The Precedent, which covers those opinions from Q3 and Q4 of 2023 that the Federal Circuit designated as precedential and worthy of publication in the Federal Reporter.

In March, the PTAB cancelled 458 (75.21%) instituted claims across 31 IPR and PGR Final Written Decisions...

In September 2017, Purdue Pharma L.P. ("Purdue") sued Collegium Pharmaceutical, Inc. ("Collegium") for infringement of US Pat. No. 9,693,961.

In February, the PTAB cancelled 397 (71.27%) instituted claims across 32 IPR and PGR Final Written Decisions, including decisions issued following remand from the Federal Circuit.

AA candidate Olayinka Braimoh tells tribunal the Kogi 2023 gubernatorial election was conducted without compliance to Electoral Act, 2022.

The candidate of the Action Alliance in the 2023 gubernatorial election in Kogi state, who is contesting the return of Ahmed Ododo,

The availability of post-grant proceedings at the Patent Trial and Appeal Board (PTAB) has changed the face of patent litigation. This periodic digest is designed to keep you up-to-date...

The US Patent & Trademark Office (PTO) Director vacated Final Written Decisions issued by the Patent Trial & Appeal Board that presented a sua sponte construction of a claim term in...

The US Court of Appeals for the Federal Circuit in Purdue Pharma L.P. v. Collegium Pharm. Inc. addressed a unique situation in November 2023 whereby the Patent Trial and Appeal Board...

Precedential Decisions - Penumbra, Inc. v. RapidPulse, Inc., IPR2021-01466, Paper 34 (March 10, 2023) (designated: November 15, 2023) (regarding prior art status under...